This bundle includes reports from each quarter of 2011. BioMedTracker quarterly outlook reports highlight select catalysts, comprising concise summaries and transparent opinions on potential market moving events to help the reader make informed investment decisions. In addition to its readability, the report contains calculated probabilities of clinical phase advancement and FDA approval within the context of drug class and disease area, thus providing an indepth look beyond a drug’s own efficacy and safety. Finally, with BioMedTracker’s sister product, CatalystTracker, catalyst calendars representing several sectors for your perusal have been generated.
2011 Outlook Report eBook Download